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Traditional Chinese medicine (TCM) products, as herbal 
treatment options for minor illnesses or functional 
ailments, have a long history in China and other Asian 
countries (1-6), and are used as complementary medicine 
even for more serious diseases in other countries including 
Germany (7). However, efforts of its worldwide distribution 
are limited as are attempts to integrate herbal TCM 
in modern medicine and vice versa (8-10), with few 
exemptions (11). Indeed, scientific and public pressure 
on herbal TCM as therapy alternative for significant 
diseases continues to focus among other difficulties on 
communicable details of clear recommendations how to 
use herbs as part of the TCM. To resolve some of these 
problems, hope came up with the recent publication on 
hormesis by Wang et al. (12). In principle, this report 
considers hormesis as a mechanistic approach to understand 
herbal treatments in TCM, whereby herbal TCM medicines 
may act through hormetic dose-response mechanisms 
reflecting components that are stimulatory at low doses and 
inhibitory at high doses in vitro. To overall disappointment, 
however, concrete clinical recommendations for individual 
diseases or herbs were only marginally provided that would 
allow guidance of physicians or establishing guidelines 
of clinical management. Similarly, poorly practicable but 
interesting to read are theoretical discussions about the 
complex TCM-related “Monarch, Minister, Assistant 
and Guide” system that vaguely attributes different 
qualifications to not further specified TCM herbs (12). For 
instance, it remains unclear for what a Monarch herb stands 
and how this can be transferred to clinical medicine that 
asks for established treatment guidelines and practicable 
solutions of dosage recommendations. However, these 
cannot be provided because ancient TCM philosophy 
proposes for prescribed TCM herbs to be tailoring to the 
patient’s symptoms, signs and constitution (13,14), whereby 
original Chinese formulae are often modified, and such 
tailoring details are rarely available (14).
Apart from hormesis issues proposed already 15 years 
ago (12) and adapted in 2017 (15), various other aspects 
related to herbal TCM treatment modalities have been 
poorly handled in the past and are of high importance, 
requiring new pragmatic approaches in order to convince 
both, potential consumers and the scientific community, 
from its potential benefit(s) (Table 1) (6-11,13,14,16-18). 
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A crucial point are randomized clinical trials (RCTs), 
commonly considered as gold standard for assessing efficacy 
with abundant results published since 1990 (6,14,16,18). 
For instance, with the search terms of “TCM herbs and 
randomized controlled trial”, publications in PubMed were 
identified in April 2016 with increasing annual frequencies 
since 1990 and an unexplained drop from 2014 to 2015 (18). 
As discussed in detail previously (6,14,16,18), low study 
quality was reported in virtually all RCTs of the overall 
TCM spectrum (16,18), which included in the majority 
herbal TCM but the trials of  herbal interventions failed 
to completely report specific characteristics of the herbal 
products used (16). Respective analyses were based on 
abundant trials, with publications ranging from 10,000 (18) 
to 26,236 (16). As an example, one of these studies was 
based on an analysis of trial results published from 1999 
to 2004 (16). Among 37,252 Chinese language articles 
identified in TCM journals published in mainland China, 
clinical trials were recognized in 26,263/37,252 articles, 
corresponding to 70.5%. Among these 26,263 clinical 
trials, 7,422 were initially identified as RCTs, equivalent 
to 28.3%, but of the 7,422 trials only 1,329 trials (17.9%) 
were truly randomized (16). In addition, some important 
methodological components of the RCTs were incompletely 
reported, such as sample size calculation (reported in 1.1% 
of RCTs), randomization sequence (7.8%), allocation 
concealment (0.3%), implementation of the random 
allocation sequence (0%), and intension to treat analysis 
(0%) (16). All reports were searched according to guidelines 
of the Cochrane Centre, and a comprehensive quality 
assessment of each RCT was completed using a modified 
version of the Consolidated Standards of Reporting Trials 
(CONSORT) checklist. Due to lacking data, uncertainty 
also prevails whether herbal TCM are at least equally 
or even more effective than conventional drugs. These 
shortcomings lead to the overall conclusion that the 
scientific quality of most published RCTs is limited and not 
suitable to propose treatment efficacy of TCM. 
Another point of concern regarding herbal TCM is 
the highly variable quality of herbal products (Table 2) 
(19-22). This issue may start with the understanding of 
plant physiology and considering plant circadian rhythms 
as being critical to manufacture good quality of herbal 
products. The circadian clock system in plants controls day 
by day different and major metabolic pathways and functions 
including photosynthesis, stomatal opening, and molecular 
processes leading to gene expression (19,20). Considering 
circadian rhythms may be an option to improve plant 
quality (20). Of note, identifying clock controlled pathways 
and processes require multidisciplinary efforts (19). In 
addition, herbal product quality is strikingly influenced by 
biotic and abiotic plant stress affecting higher plants (21). 
In detail, biotic stress is caused by pathogen attacks of other 
living organisms such as insects and larger grazing animals, 
parasites, bacteria, viruses, and funghi. As opposed, abiotic 
stress is of environmental origin and triggered by heavy UV 
radiation, draft, wounding, or soil contamination by salts or 
heavy metals. Plant stress leads to oxidative stress through 
generation of free radicals including reactive oxygen species 
(ROS), it damages the integrity of the plant, and it is often 
the cause of limited herbal product quality. Emphasis 
should also be put on technical details such as extraction 
media used to prepare herbal products. Most traditional 
herbal medicines are decoctions and therefore water based 
Table 1 Suggestions for improvements related to herbal TCM treatment
Suggestions for improvements References 
RCTs are needed to evaluate  efficacy and risks of herbal TCM treatment Wang et al., 2007 (16);  
Teschke et al., 2015 (14) 
For assessing possible rare adverse events such as liver injury, prospective studies are required for 
valid data
Melchart et al., 2017 (7)
Clinical data, relevant review articles, meta-analyses, and reports of RCTs should be presented in 
English language journals
Han et al., 2018 (17)
Indications should be transferred from Chinese traditional concepts and diagnosis to worldwide 
accepted ICD diagnoses
Melchart et al., 2017 (7)
Contraindications are to be defined Teschke et al., 2015 (14)
Treatment modalities need definition including form of application, daily dose and duration of use Melchart et al., 2017 (7)
TCM, traditional Chinese medicine; RCT, randomized controlled trials; ICD, international classification of diseases.
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products. Nevertheless, regulators should clearly define for 
each herbal medicine the obligatory solvent for product 
manufacturing to ensure some degree of product uniformity. 
Indeed, there are substantial differences of phytochemical 
yield depending on the solvent used that include in addition 
to water also the synthetic products acetone, chloroform, 
methanol, and hexane (22). 
Plant quality is also dependent on seasonal variation and 
area of harvest, as discussed and referenced in detail (19). 
For instance, this dependency on the harvest time was 
shown recently for the roots of Cyathula officinalis, a popular 
herbal TCM. Using a metabolomic approach based on gas 
chromatography-mass spectrum, 166 metabolites had been 
identified in these roots, 63 of which showed significant 
quantitative changes in different growth years of up to four 
years. It was suggested to harvest in the fourth grow year in 
order to boost herbal quality and extending these studies to 
other plants. Such studies about variation of phytochemicals 
in different harvest times are in line with Good Agricultural 
Standards of Chinese traditional herbs in China. Fixing 
the harvest year will provide consistency of batches and 
herbal products with the desired phytochemicals as target 
ingredients (19). Initially unexpected were results obtained with 
Polygonum multiflorum (PM), harvested from various regions 
of China and assessed for its hepatotoxic potential (19). This 
is of importance because PM is much used in China and 
elsewhere, known for its risk of liver injury. Indeed, liver 
toxicity was different among the various areas of harvest, 
and the most toxic PM was from the Sichuan Province. 
Studies also revealed that emodin was not considered the 
main hepatotoxin anymore, as opposed to previous studies. 
Preference is now given to both, tetrahydroxystilbene-O-
(galloyl)-hex and emodin-O-hex-sulfate as the primary 
offending agents (19).
Among the unresolved clinical challenges, toxicity 
risks are associated with the use of herbal TCM (Table 2), 
especially reported cases of liver injury with partially high 
frequencies (6). Whereas the etiology of liver injury is clear 
in patients from China who used TCM herbs that contained 
unsaturated pyrrolizidine alkaloids (PAs) and developed 
typically the hepatic sinusoidal obstructive syndrome 
(SOS), the pathogenic background of liver injury by other 
TCM herbs often remains unclear and might partially be 
attributed to impurities or adulterants, requiring further 
analyses (Table 2) (6,19). 
As opposed to literature data (6), results of a recent 
study revealed a very low incidence of liver injury among 
patients treated with herbal TCM (7). This report from 
Germany presented for the first time liver injury data 
derived from a prospective, hospital based and large 
scale study of 21,470 patients, who had no liver disease 
prior to treatment with herbal TCM (7), in which product 
falsification and adulteration were excluded (7,23), 
commonly found in other TCM products (19). Products 
used in the German hospital were also screened for 
microbial contaminations, aflatoxins, pesticides, and the 
heavy metals Lead, Cadmium, Mercury, and Arsenic (7,23). 
Among the 21,470 patients under herbal TCM treatment, 
26 patients (0.12%) experienced abnormal serum liver 
values of alanine aminotransferase (ALT) ≥5 × ULN (upper 
Table 2 Required improvements of herbal traditional Chinese medicine (TCM) product quality
Critical quality issues of herbal TCM products References 
To improve herbal product quality, consideration should be paid in the future to plant physiology with 
its circadian clock system
Teschke et al., 2018 (19); 
Dakhiya et al., 2017 (20)
Plant stress due to production of reactive oxygen species (ROS) is increasingly considered as cause of 
suboptimal plant quality
Teschke et al., 2018 (19); 
Xuan et al., 2016 (21)
Factors such as seasonal variation and areas of harvest should be more considered to keep plant 
quality at a high level
Teschke et al., (19)
Herbal product quality may be altered depending on the used solvent Xuan & Teschke, 2015 (22)
Plant quality depends among others on seasonal variation with time of harvest, and on area of harvest Teschke et al., 2018 (19)
Avoidance of treatment with herbal TCM products that are contaminated by impurities, misidentified 
herbs, or heavy metals like Lead, Cadmium, Mercury, and Arsenic or adulterated by conventional 
drugs 
Melchart et al., 2017 (7); 
Teschke et al., 2018 (19); 
Melchart et al., 2016 (23)
Mandatory use of analytical procedures in TCM products for authenticity, international botanical 
nomenclature and modern scientific based processing of raw drugs
Melchart et al., 2016 (23); 
Melchart et al., 2017 (7)
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limit of normal), namely 300.0±172.9 U/L, mean ± SD, 
suggesting mild to moderate degrees of liver injury (7). Case 
evaluation was completed with respect to causality, assessed 
with the Roussel Uclaf Causality Assessment Method 
(RUCAM) in all 28 patients. RUCAM-based causality 
for TCM herbs was probable in 8/26 patients, possible in 
16/26, and excluded in 2/26 cases. This study was carried 
out from 1994 to 2015 and showed 24 liver injury cases with 
a possible or probable RUCAM grading, corresponding to 
24/21,470 cases and a tentative incidence rate of around 
1.1‰. The low number of newly detected liver injury 
cases (7) is at variance to the large lists of liver injury cases 
presumably related to herbal TCM treatment, published 
mainly in Asian countries (6,19). It is unclear whether the 
high quality standard applied to the herbal TCM products 
used in the German hospital may have contributed to the 
low number of liver injury cases (7,19,23). 
Our editorial hopefully encourages scientists and 
regulators to improve overall conditions of herbal 
TCM treatment by providing more evidence for a 
favourable benefit to risk constellation. In fact, China 
is rich in biologically active plants, which grow over a 
large fascinating landscape and provide abundant active 
molecules, favoring the early development of local herbal 
TCM (24). About 13,000 herbal preparations are used, 
listed in the Chinese Materia Medica (CMM), and available 
in China; they are officially recognized and described in 
detail by the Chinese Pharmacopeia, including herbs that 
are commonly used or represent regional variations and 
folk medicine variants. The Chinese Materia Medica is a 
reference book that also describes details of thousands of 
plant preparations, including some nonbotanical elements 
such as animal parts and minerals, which are incorrectly 
classified as herbal medicines. Outside of China, only 
around 500 Chinese herbs are commonly used. The plants 
of the Chinese Materia Medica contain multiple molecules 
as hidden champions for the development of potent drugs 
to be synthetized by the pharmaceutical industry.
Needless to say, the reputation of herbal TCM has 
substantially gained within the past few years, achieved 
through research on developing new drugs including 
artemisinin, as discussed and referenced in detail (6,19,25); 
a short summary on the discovery and development of 
artemisinin is warranted as encouragement to younger 
scientists how good scientific work can be achieved (6,19). 
The Nobel Prize for Medicine or Physiology 2015 will 
certainly further inspire modern TCM research in the near 
future, although the Nobel Prize committee did not specify 
that the prize be to TCM. Instead, the 2015 Nobel Prize 
awarded Youyou Tu as scientist for her pioneering work 
of drug development originating from herbal TCM and 
her discovery of artemisinin for the treatment of malaria. 
Artemisinin is derived from the herbal TCM Qing Hao 
(Artemisia annua L.), known since more than two thousand 
years as a Chinese herbal medicine for various ailments. 
The initial breakthrough in the discovery of artemisinin 
dates back to 4 October 1991, when an extract derived 
from Artemisia annua was found 100% effective against 
parasitemia in mice infected with Plasmodium berghei and 
in monkeys with Plasmodium cynomolgi. After ascertaining 
that the extract was safe for human use, clinical efficacy was 
tested in the Chinese Hainan province in trials with patients 
infected with both Plasmodium vivax and Plasmodium 
falciparum . The results were encouraging: patients 
treated with the extract experienced rapid disappearance 
of symptoms such as fever and decrease of parasitemia, 
whereas patients receiving chloroquine did not. Artemisinin 
and its derivatives such as artesunate and artemether are 
now successfully used to treat patients with malaria by 
Plasmodium vivax or Plasmodium falciparum, preferring a 
combination with antimalarial drugs other than artemisinin, 
called artemisinin-based combination therapies (ACTs), 
and banning artemisinin-based monotherapy that may 
promote the risk of antimalarial drug resistance. Malaria 
is transmitted among humans by female mosquitoes of the 
Anopheles genus, which take blood meals from patients 
with malaria to carry out egg production; such blood meals 
are the link between the human and the mosquito hosts in 
the parasite life circle and enable transfer malaria through 
biting humans by infected mosquitoes. Based on treatment 
with ACTs together with other approaches such as use of 
insecticides and insecticides-treated mosquito nets, the 
WHO stated that the number of patients with malaria 
and malaria-related mortality has been drastically reduced 
within the past years, and there is no question that most 
of this improvement is attributable the work of Youyou Tu 
with Artemisia annua.
From the TCM herb Artemisia annua to the active 
molecule and the beneficial drug was a long but successful 
way of drug research and development. This is not in line 
with mainstream philosophy of herbal TCM that prefers 
the use of a bundle of herbs rather than to focus on a single 
herb or even a single molecule, as opposed to what Youyou 
Tu did. In 1996 she started her project against malaria by 
investigating more than 2,000 Chinese herbal preparations 
and identified 640 hits that had possible antimalarial hits. 
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More than 380 extracts obtained from around 200 herbs were 
evaluated, and a high antimalarial activity was found in an 
extract derived from Artemisia annua as prepared according 
to “A Handbook of Prescriptions for Emergencies” by Ge 
Hong (248–346 AD). Originating from artemisinin with 
a molecular weight of 282 Da and a molecular formula 
of C15H22O5, dihydroartemisinin was found to be more 
stable and ten times more effective than artemisinin, and 
adding a hydroxyl group to the molecule provided more 
opportunities for developing new artemisinin derivatives 
through esterification. The fascinating route from a TCM 
herb via a molecule to a drug is finally highlighted again 
at the molecular level, now in the human erythrocytes 
infected with plasmodia. The molecular basis of treatment 
efficacy includes among several mechanisms the cleavage 
of artemisinin’s endoperoxide bridge by a Fe(II) Fenton, 
which is facilitated by heme-iron originating from 
hemoglobin degradation in the parasites’ food vacuoles. 
Autodigestion of plasmodium food vacuoles is achieved 
following their damage by hydroxyl radicals and superoxide 
anions. Consequently, artemisinin with its derivatives is a 
drug with a specific molecular target in a specific parasitic 
disease; toxicity has not been found in clinical studies with 
normal doses. Expectations are high that more hidden drug 
champions can be derived from herbal TCM with high 
efficacy and little harm, providing a favorable benefit-risk 
profile.
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